Marc R. Blackman

Professor

1978 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Marc R. Blackman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Growth Hormone Medicine & Life Sciences
Insulin-Like Growth Factor I Medicine & Life Sciences
Testosterone Medicine & Life Sciences
Dehydroepiandrosterone Medicine & Life Sciences
Serum Medicine & Life Sciences
Hormones Medicine & Life Sciences
Aging of materials Chemical Compounds
Prostatic Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1978 2019

Association between muscle strength and modeling estimates of muscle tissue heterogeneity in young and old adults

Harris-Love, M. O., Gonzales, T. I., Wei, Q., Ismail, C., Zabal, J., Woletz, P., Dipietro, L. & Blackman, M. R., Jan 1 2019, In : Journal of Ultrasound in Medicine. 38, 7, p. 1757-1768 12 p.

Research output: Contribution to journalArticle

Muscle Strength
Young Adult
Statistical Models
Muscles
Hand Strength

Effects of growth hormone on hepatic insulin sensitivity and glucose effectiveness in healthy older adults

Forrest, L., Sedmak, C., Sikder, S., Grewal, S., Harman, S. M., Blackman, M. R. & Muniyappa, R., Jan 1 2019, (Accepted/In press) In : Endocrine.

Research output: Contribution to journalArticle

Growth Hormone
Insulin Resistance
Glucose
Liver
Placebos

Differential expression of Annexin 2, SPINK1, and Hsp60 predict progression of prostate cancer through bifurcated WHO Gleason score categories in African American men

Beyene, D. A., Naab, T. J., Kanarek, N. F., Apprey, V., Esnakula, A., Khan, F. A., Blackman, M. R., Brown, C. A. & Hudson, T. S., Jan 1 2018, (Accepted/In press) In : Prostate.

Research output: Contribution to journalArticle

Chaperonin 60
Annexins
Neoplasm Grading
Protease Inhibitors
African Americans

Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial

Lam, P. H., Dooley, D. J., Fonarow, G. C., Butler, J., Bhatt, D. L., Filippatos, G. S., Deedwania, P., Forman, D. E., White, M., Fletcher, R. D., Arundel, C., Blackman, M. R., Adamopoulos, C., Kanonidis, I. E., Aban, I. B., Patel, K., Aronow, W. S., Allman, R. M., Anker, S. D., Pitt, B. & 1 others, Ahmed, A., Feb 1 2018, In : European Journal of Heart Failure. 20, 2, p. 359-369 11 p.

Research output: Contribution to journalArticle

Enalapril
Left Ventricular Dysfunction
Heart Failure
Placebos
Hospitalization

Characteristics and Incidence of Chronic Illness in Community-Dwelling Predominantly Male U.S. Veteran Centenarians

Kheirbek, R. E., Fokar, A., Shara, N., Bell-Wilson, L. K., Moore, H. J., Olsen, E., Blackman, M. R. & Llorente, M. D., 2017, (Accepted/In press) In : Journal of the American Geriatrics Society.

Research output: Contribution to journalArticle

Independent Living
Veterans
Chronic Disease
Incidence
Atrial Fibrillation